4.3 Article

Visualoutcomesandsafety of an extended depth-of-focus intraocular lens: results of a pivotal clinical trial

Journal

JOURNAL OF CATARACT AND REFRACTIVE SURGERY
Volume 48, Issue 3, Pages 288-297

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/j.jcrs.0000000000000747

Keywords

-

Funding

  1. Johnson Johnson Vision

Ask authors/readers for more resources

This study compared the effectiveness and safety of the TECNIS Symfony intraocular lens (IOL; ZXR00) with the TECNIS 1-piece monofocal IOL (ZCB00). The results showed that the TECNIS Symfony IOL provided comparable distance vision and improved intermediate and near vision, with decreased spectacle wear.
Purpose: To compare the effectiveness and safety of the TECNIS Symfony intraocular lens (IOL; ZXR00) with the TECNIS 1-piece monofocal IOL (ZCB00). Setting: 15 sites in the United States. Design: Prospective, randomized, patient-masked/evaluator-masked clinical trial. Methods: Randomized participants received either the ZXR00 or ZCB00 IOL bilaterally. The 6-month postoperative outcomes included monocular and binocular distance, intermediate, and near visual acuity (VA), spherical equivalent refraction and refractive cylinder, spectacle wear, and visual symptoms. Results: Overall, 299 patients were implanted with a study IOL (ZXR00 IOL, n = 148; ZCB00 IOL control, n = 151). At the 6-month follow-up, mean binocular uncorrected distance VA was comparable between ZXR00 and ZCB00 IOL recipients (P =.1011). The ZXR00 IOL group had significantly better mean binocular uncorrected intermediate VA and uncorrected near VA (both P <.0001) than the ZCB00 IOL group. The mean binocular distance-corrected intermediate VA and distance-corrected near VA were also better in the ZXR00 IOL group (both P <.0001). More ZXR00 IOL recipients reported wearing spectacles none of the time or a little of the time for overall vision at 6 months compared with the ZCB00 IOL group (85.0% vs 59.9%, P <.0001). In the ZXR00 IOL-implanted patients, low incidence rates of night glare (mild to moderate, 2.7%), halo (mild to moderate, 13.6%; severe, 2.7%), and starbursts (mild to moderate, 7.5%; severe, 1.4%) were reported. Conclusions: The TECNIS Symfony IOL provided comparable distance vision and improved uncorrected and distance-corrected intermediate and near vision, along with decreased spectacle wear and low incidence rates of dysphotopsia, compared with the TECNIS 1-piece monofocal IOL. (C) 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of ASCRS and ESCRS

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery

Syd L. Tyson, Shamik Bafna, Joseph P. Gira, Damien F. Goldberg, Jason J. Jones, Michael P. Jones, Janet K. Kim, Joseph M. Martel, Michael L. Nordlund, Ian K. Piovanetti-Perez, Inder Paul Singh, Jamie Lynne Metzinger, Deepa Mulani, Swati Sane, Jonathan H. Talamo, Michael H. Goldstein, Louis Alpem, Y. Ralph Chu, Neel Desai, Alice Epitropoulos, John F. Kozlovsky, Mark Lesher, Ranjan P. Malhotra, Newton T. Peters, Francis W. Price, Tariq Qamar, Steven M. Silverstein, Navin H. Tekwani, David T. Vroman

JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2019)

Article Ophthalmology

Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma

Jason Jones, Douglas D. Koch, Steven Vold, Cathleen McCabe, Douglas Rhee, Richard Lewis, Stephen Smith, Quang H. Nguyen, Thomas W. Samuelson, Tom Walters, Robert Marquis, Brian Flowers, Jason Jones, Steven D. Vold, Stephen E. Smith, Gary Foster, Brennan P. Greene, Dan B. Tran, Husam Ansari, Kenneth Olander, Neil Atodaria, Cathleen McCabe, Richard Lewis, Mujtaba Qazi, Quang Nguyen, Edward Meier, David Godfrey, Mohammed ElMallah, Jason Levine, C. Stark Johnson, E. Randy Craven, Richard D. Hawkins, William Clifford, Inder Paul Singh, Y. Ralph Chu, Alan C. Crandall, Douglas Rhee

JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2019)

Article Ophthalmology

Three-Year Findings of the HORIZON Trial A Schlemm Canal Microstent for Pressure Reduction in Primary Open-Angle Glaucoma and Cataract

Iqbal Ike K. Ahmed, Douglas J. Rhee, Jason Jones, Inder Paul Singh, Nathan Radcliffe, Gus Gazzard, Thomas W. Samuelson, Jeb Ong, Kuldev Singh

Summary: The 3-year outcomes of the multicenter randomized clinical trial comparing cataract surgery with Hydrus Microstent implantation versus cataract surgery alone showed that eyes implanted with the microstent had lower intraocular pressure, required fewer medications, and were less likely to need further incisional glaucoma surgery.

OPHTHALMOLOGY (2021)

No Data Available